Abstract
The orexin-A/hypocretin-1 and orexin-B/hypocretin-2 are neuropeptides synthesized by a cluster of neurons in the lateral hypothalamus and perifornical area. Orexin neurons receive a variety of signals related to environmental, physiological and emotional stimuli, and project broadly to the entire CNS. Orexin neurons are “multi-tasking” neurons regulating a set of vital body functions, including sleep/wake states, feeding behavior, energy homeostasis, reward systems, cognition and mood. Furthermore, a dysfunction of orexinergic system may underlie different pathological conditions. A selective loss orexin neurons was found in narcolepsia, supporting the crucial role of orexins in maintaining wakefulness. In animal models, orexin deficiency lead to obesity even if the consume of calories is lower than wildtype counterpart. Reduced physical activity appears the main cause of weight gain in these models resulting in energy imbalance. Orexin signaling promotes obesity resistance via enhanced spontaneous physical activity and energy expenditure regulation and the deficiency/dysfunction in orexins system lead to obesity in animal models despite of lower calories intake than wildtype associated with reduced physical activity. Interestingly, orexinergic neurons show connections to regions involved in cognition and mood regulation, including hippocampus. Orexins enhance hippocampal neurogenesis and improve spatial learning and memory abilities, and mood. Conversely, orexin deficiency results in learning and memory deficits, and depression.
Introduction
Orexin A and B are excitatory hypothalamic neuropeptides playing a relevant role in different physiologic functions such as sleep/wake rhythms and thermoregulation, control of energy metabolism, cardiovascular responses, feeding behavior, and spontaneous physical activity (SPA).
At the end of the last century, Sakurai et al. (1998) firstly described Hypocretins 1 and 2 as regulators of feeding and appetite behavior, produced in a specific hypothalamic region (Edwards et al., 1999; Haynes et al., 2000, 2002).
More recent studies focused the attention on the role of the orexins in mood and emotional regulation, energetic homeostasis, reward mechanisms, drug addiction, arousal system, and sleep and wakefulness (Peyron et al., 2000; Thannickal et al., 2000; Hara et al., 2001; Yamanaka et al., 2003a; Harris et al., 2005; Narita et al., 2006). However, the function of orexins in metabolism pathways are far to be completely understood.
The orexin/hypocretin system
In Mammals, orexin A and orexin B are synthesized in the lateral hypothalamic and perifornical areas (Peyron et al., 1998; Nambu et al., 1999), starting from a common polypeptide precursor (prepro-orexin) through proteolytic processing (Figure 1).
Figure 1
Orexin A is a neuropeptide composed of 33 amino acids with an amino(N)-terminal pyroglutamyl residue, two intra-chain disulphide bonds and carboxy (C)-terminal amidation, while Orexin B is a linear neuropeptide sized 28 amino acids, C-terminally amidated. The N-terminal portion presents more variability, whilst the C-terminal portion is similar between the two subtypes. The orexins activity is modulated by their specific receptors (OX1R, OX2R). OX1R presents higher affinity for orexin A than B and transmits signals throughout the G-protein class activating a cascade that leads to an increase in intracellular calcium concentration. By contrast, OX2R binds the two subtypes of orexin with similar affinities, probably associated to a G inhibitory protein class (Xu et al., 2013). These differences seem to suggest different physiological roles for OX1R and OX2R (Trivedi et al., 1998). Different physiological roles of OX1R and OX2R seem to be supported by the observation that mRNAs receptors show complementary distribution patterns (Figure 2):
Figure 2
- OX1R is distributed in prefrontal and infralimbic cortex (IL), hippocampus (CA2), amygdala, stria terminalis bed nucleus (BST), PVT, anterior hypothalamus, dorsal raphe (DR), ventral tegmental area (VTA), locus coeruleus (LC), and laterodorsal tegmental nucleus (LDT)/pedunculopontine nucleus (PPT) (Trivedi et al., 1998; Lu et al., 2000);
- OX2R is distributed in amygdala, TMN, Arc, dorsomedial hypothalamic nucleus (DMH), paraventricular nucleus (PVN), LHA, BST, PVT, DR, VTA, LDT/PPT, CA3 in the hippocampus, and medial septal nucleus (Lu et al., 2000).
Modulation of orexin neurons
Electrophysiological studies on transgenic mice have identified several neurotransmitters and neuromodulators influencing the activation or inhibition in orexin neurons activity. Specifically, GABA (Xie et al., 2006), noradrenaline and serotonin seem to inhibit the activity of orexin neurons (Yamanaka et al., 2003b), as dopamine acts through activation of α2-adrenoceptors (Yamanaka et al., 2006). Moreover, agonists of ionotropic glutamate receptors tend to excite orexin neurons, while glutamate antagonists inhibit their activity (Li et al., 2002) indicating that glutamatergic neurons can tonically activate orexin neurons. Cholecystokinin, neurotensin, oxytocin, and vasopressin enhance orexin neurons activity (Tsujino et al., 2005; Tsunematsu et al., 2008) by modulation of adenosine and CO2 concentrations (Liu and Gao, 2007; Williams et al., 2007).
Sleep/wake regulation
Interestingly, orexin system seems to be crucial for maintenance of wakefulness state, as demonstrated by narcolepsy caused by orexin deficiency in Human and Animals (Chemelli et al., 1999; Lin et al., 1999). Narcolepsy is a neurological disease affecting ~1 in 2,000 individuals in the United States (Mignot, 1998), characterized by chronic daytime sleepiness, sleep attacks, and possibility of cataplexy, hypnagogic hallucinations and sleep paralysis. These symptoms are not necessary to be present all together and narcolepsy may be identified and diagnosed by standard polysomnography (PSG) at all ages, including childhood. Narcolepsy is the results of orexin-containing neurons loss, which tend to increase their activity during wakefulness activating aminergic nuclei such as locus coeruleus, raphe nuclei, and tuberomamillary nucleus with maintaining wake state and preventing of inappropriate transitions into sleep, particularly REM sleep phases (Saper et al., 2001; España and Scammell, 2011). Narcolepsy is usually classified into two subtypes: (a) Narcolepsy with cataplexy (type 1); and (b) Narcolepsy without cataplexy (type 2). On the other hand, the orexin in sleep/wake regulation and pathophysiology of narcolepsy may be not limited to the activation/deactivation of cataplexic phenomena and/or sleep attacks. In fact, affected children and adolescents present specific cognitive impairments (Posar et al., 2014), which pinpoint the close relationship between sleep and cognition (Esposito and Carotenuto, 2014). Moreover, probably due to the same role in sleep modulation, orexin seems to be also involved in the pathogenesis of migraine (Rainero et al., 2008) as suggested by the link between NREM sleep instability and risk of cognitive impairments and behavioral problems (McCoy and Strecker, 2011; Bruni et al., 2012; Colonna et al., 2015; Carotenuto et al., 2016, Figure 3).
Figure 3
Feeding behaviors and energy homeostasis
Orexin A seems to regulate feeding behaviors and energy expenditure as evidenced by the intracerebroventricular (icv) injection of orexins effects during the light period, which induces feeding behavior in rodents and zebrafishes, probably for a direct action on lateral hypothalamic area containing neurons modulated by glucose concentration. In fact, the high concentrations of glucose and leptin tend to hyperpolarize orexinergic neurons, while low concentrations of glucose and ghrelin depolarize them. Therefore, the orexinergic system discriminate physiological variation in glucose levels due to meals modulating in this way energy balance according to food intake (Monda et al., 2008; Messina et al., 2014). Moreover, transgenic mice with gradual and then loss of hypothalamic orexin-containing neurons show feeding abnormalities and dysregulation in energy homeostasis determining obesity despite the reduction of food intake/calories. Interestingly, it has been reported an increased prevalence of obesity in narcoleptic subjects in all ages (Yokobori et al., 2011).
Shiuchi et al. (2009) observed that the regulation mediated by orexinergic system on muscle glucose metabolism is due to activation of β2-adrenergic signaling and consequently peripheral energy expenditure. A persistent wake-state mediated by orexins could also be important for food intake motivation. When facing reduced food availability, animals adapt with a longer awake period, revolutionizing their normal pattern of activity (Viggiano et al., 2009). During starvation the activation of orexin neurons mediated by low leptin and glucose levels, might modulate their activity according to energy expenditure and stores to maintain wakefulness, whilst orexin neuron-ablated mice fail to respond to fasting with increased wakefulness and activity (Viggiano et al., 2010; Messina et al., 2013; Chieffi et al., 2017; Villano et al., 2017). These data confirm that orexin neurons mediate energy balance and arousal, maintaining a consolidated state of wakefulness in hungry animals in order to promote alertness.
The role of orexin system in obesity
Obesity is a complex multifactorial condition lowering health quality and many effects such as metabolic syndrome, type 2 diabetes mellitus, coronary heart disease, sleep apnea syndrome, and reduced in life expectancy (Must et al., 1999). In the last decades, the incidence of obesity has increased both in children and adults worldwide (Flegal et al., 2010). Environmental and genetic factors cause large variations among human susceptibility to obesity. Physical activity and the so called “non-exercise induced thermogenesis” (NEAT) are factors determining this variability and susceptibility. The term NEAT includes all types of energy expenditure not associated with formal exercise, such as standing and fidgeting (Levine, 2002). A complementary concept to that of NEAT is the spontaneous physical activity (SPA) describing any type of physical activity not qualified as voluntary exercise. Together NEAT and SPA are hereditable but not interchangeable, because NEAT refers to energy expenditure while SPA describes the types of physical activity resulting in NEAT. Therefore, SPA induces an important variability in sensitivity to obese subject that spend less time standing than leans (Levine et al., 2005). Orexin signaling would promote obesity resistance via enhanced SPA and energy expenditure regulation and the deficiency/dysfunction in orexins system lead to obesity in animal models despite of lower calories intake than wildtype associated with reduced physical activity. On the other hand, the body weight regulation seems to be complex according to the lack of orexin neurons. In 2012, Perez-Leighton et al. (2012) highlighted the protective role of intratecal administration orexin A against obesity in mice models.
Orexin A has also been discovered to promote SPA and NEAT as effect of administration into specific cerebral areas (i.e., rostral LH, hypothalamic paraventricular nucleus, nucleus accumbens, locus coeruleus, dorsal raphe nucleus, tuberomamillary nucleus, substantia nigra, Hara et al., 2005). In this light, orexinergic neurotransmission may be an interesting and new pharmacologic target for obesity therapy (Zink et al., 2014). Low levels of orexin in CNS and peripheral tissues were found in animal models of obesity diet-induced (Hara et al., 2005), and adipose tissue in obese humans subjects showed lower concentrations of orexin and reduced in its receptors activity (Hara et al., 2005). A study conducted by Levin et al. (1997) on Sprague Dawley rats showed that models fed with a high-fat diet gained no more weight than chow-fed controls. Obesity prone (OP) and obesity resistant (OR) models present different profiles in weight gaining despite of no differences in energy intake (Levin et al., 1997; Messina et al., 2015; Messina A. et al., 2016). The OR group showed lower body weight and fat mass on a low-fat diet and gain less weight when fed with high-fat diet than OP group. Furthermore, OR rats lean group suggest that the negative caloric benefit of OXA-induced SPA appears to outweigh the positive calories due to OXA-induced hyperphagia (Levin et al., 1997; Carotenuto et al., 2010; Esposito et al., 2013). OXA action on SPA had a longer duration when compared with that above food intake (Carotenuto et al., 2011; Bellini et al., 2013); OR rats have higher endogenous SPA thus reflecting their higher sensitivity to SPA- promoting stimuli such as lower caloric intake. By contrast OP rats displayed lower SPA endogenous levels after a high-fat diet administration if compared to their OR group counterpart (Levin et al., 1997; Esposito et al., 2012a). Conversely, obesity tends to increase also the prevalence of migraine in all ages of life (Esposito et al., 2012b; Verrotti et al., 2012, 2015).
Reward system
Orexin system seems to play a unified role in coordinating motivational activation under numerous behavioral conditions (James et al., 2016) as showed, for example, by its involving in alcohol use and drug-addiction (Martin-Fardon et al., 2016; Walker and Lawrence, 2016). Recent studies focused their attention on reward system modulation by orexin system. Treating narcoleptic patients with amphetamine-like drugs (Di Bernardo et al., 2014) did not lead to addiction to these drugs (Monda et al., 2014). Wild-type mice are more susceptible to developing morphine dependence in comparison with orexin knockout mice (Chieffi et al., 2014b). Furthermore, reward brain circuits in humans affected by narcolepsy were identified as abnormal (Viggiano et al., 2014) However, the mismatch between predicted reward and reward subsequently received was significantly higher in Parkinson's disease (PD) compared to narcoleptic, independent of reward magnitude and valence as showed by cataplexy that may be triggered by both positive and negative emotions (Mensen et al., 2015).
Regulatory mechanisms at the base of reward system are shown in Figure 4. It seems to be clear that orexin neurons modulate reward system and play a predominant role in mechanisms of drug addiction. Many reports suggest a critical role of orexin signaling in neural plastic effects at glutamatergic synapses in the ventral tegmental area (VTA) (Figure 4).
Figure 4
Links with brain
Animal studies suggest that orexinergic system may enhance hippocampal neurogenesis influencing learning and memory processes. In 2004, Wayner et al. (2004) reported that local dentate gyrus perfusion with orexin-A in anesthetized rats enhanced long-term potentiation (LTP) strengthen the link between structural and functional hippocampal plasticity. Moreover, Wayner et al. (2004) showed that LTP enhancement may be blocked in SB-334867 pre-treated rats SB-334867, a specific Ox1R antagonist (Wayner et al., 2004). The effects of dentate gyrus-OX1Rs antagonization on LTP occurred also in freely moving rats impairing spatial memory in Morris water maze (Wayner et al., 2004). Some studies examined the effects of the administration of orexin-A in rats treated with Pentylenetetrazol (PTZ) (Zhao et al., 2014). PTZ induces seizures resulting in the hippocampal atrophy, learning and memory deficits and decrease of cerebrospinal fluid-level of orexin-A (Coppola et al., 2010), while the intracerebroventricular injection of orexin-A in PTZ-kindled rats tend to attenuate these impairments, enhancing neurogenesis in the dentate gyrus (Zhao et al., 2014). Interestingly, in rats treated with orexin-A more than 50% of newborn cells differentiated into neurons, whereas only approximately 30% of the newborn cells differentiated into neurons in the control group (Zhao et al., 2014).
Moreover, Orexin-A seems to be implicated in social memory, the ability to distinguish and remember familiar from novel conspecifics (Yang et al., 2013). Yang et al. (2013) reported that orexin/ataxin-3-transgenic (AT) mice, in which orexin neurons degenerate by 3 months of age, displayed deficits in long-term social memory. Nasal administration of exogenous orexin-A restored social memory and enhanced synaptic plasticity in the hippocampus (Yang et al., 2013). A decrease of Orexin-A was found in animal models of depression and its intracerebroventricular administration reduced depression symptoms and increases the number of cells in the dentate gyrus (Arendt et al., 2013). Then, it is possible that the enhancement of cell proliferation in the dentate gyrus by orexin-A might have an antidepressive-like effect.
Interestingly, physical exercise produces an increase of orexin-A level in cerebrospinal fluid of rats, dogs and cats, and in plasma of humans (Messina G. et al., 2016). Note that the orexin-A rapidly cross the blood-brain barrier, probably by simple diffusion, having a high degree of lipophilicity. Furthermore, physical exercise is (a) an effective tool for enhancing cognitive performance and regulating mood and (b) produced morphological and functional changes of brain regions that play central roles in successful everyday functioning, such as frontal and temporal cortices, and the hippocampus located in the inner (medial) region of the temporal lobe. The frontal lobe is important for cognitive function (Iavarone et al., 2007; Chieffi et al., 2009, 2012; Boscia et al., 2015), the temporal lobe for memory function (Chieffi et al., 2004, 2014a, 2015; Marra et al., 2013; Franco et al., 2014). The factors most likely involved in exercise-induced hippocampal neurogenesis are the microcirculation and the production of neurotrophic factors such as the BDNF, VEGF, and IGF-1 (Cotman et al., 2007). Another putative factor that might contribute to the beneficial effects of exercise is the orexin-A.
Concluding remarks
Orexin is necessary for healthy life because of the important and relevant homeostatic functions controlled and organized directly or not. Orexin role is not only limited to the brain areas, because it involved also in metabolic regulation.
Statements
Author contributions
AM, VM, AV, IV, MR: conceived the study, participated in its design, and wrote the manuscript. FP, DT, MS, NF, FN, LC, EN: contributed to the conception and design. SC, MC, VD, GC, MPM, DI, MM, GM: drafted the article and revised it critically for important intellectual content. DI revised grammar and English form; GM: final approval of the version to be published. All authors read and approved the final manuscript.
Funding
This study was supported by grants of “Section of Human Physiology and Unit of Dietetic and Sport Medicine and Department of Experimental Medicine,” Università degli Studi della Campania “L. Vanvitelli”.
Conflict of interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The reviewer IS declared a shared affiliation, though no other collaboration, with several of the authors MC, FP, MR to the handling Editor, who ensured that the process nevertheless met the standards of a fair and objective review.
- SPA
spontaneous physical activity
- OX1R
orexin receptor 1
- OX2R
orexin receptor 2
- IL
infralimbic cortex
- CA2
hippocampus CA2 area
- BST
stria terminalis bed nucleus
- PVT
paraventricular thalamus
- DR
dorsal raphe
- VTA
ventral tegmental area
- LC
locus coeruleus
- LDT
laterodorsal tegmental nucleus
- PPT
pedunculopontine nucleus
- TMN
tuberomammillary nucleus
- Arc
arcuate nucleus
- DMH
dorsomedial hypothalamic nucleus
- PVN
paraventricular nucleus
- LHA
Lateral hypothalamic area
- BST
bed nucleus of the stria terminalis
- PVT
paraventricular nucleus of hypothalamus
- GABA
gamma-aminobutyric acid
- CO2
carbon dioxide
- PSG
standard polysomnography
- NREM
Non-Rapid eyes movement
- ICV
intracerebroventricular
- NEAT
non-exercise induced thermogenesis
- SPA
spontaneous physical activity
- LH
lateral hypothalamus
- CNS
central nervous system
- OP
obesity prone
- OR
obesity resistant
- PD
Parkinson's disease
- VTA
ventral tegmental area
- LTP
long-term potentiation
- PTZ
Pentylenetetrazol
- AT
orexin/ataxin-3-transgenic
- BDNF
Brain-derived neurotrophic factor
- VEGF
vascular endothelial growth factor
- IGF-1
insuline-like growth factor.
Abbreviations
References
1
ArendtD. H.RonanP. J.OliverK. D.CallahanL. B.SummersT. R.SummersC. H. (2013). Depressive behavior and activation of the orexin/hypocretin system. Behav. Neurosci.127, 86–94. 10.1037/a0031442
2
BelliniB.ArrudaM.CescutA.SaulleC.PersicoA.CarotenutoM. (2013). Headache and comorbidity in children and adolescents. J. Headache Pain.14:79. 10.1186/1129-2377-14-79
3
BosciaF.PassaroC.GigantinoV.PerdonàS.FrancoR.PortellaG. (2015). High levels of GPR30 protein in human testicular carcinoma in situ and seminomas correlate with low levels of estrogen receptor-beta and indicate a switch in estrogen responsiveness. J. Cell. Physiol.230, 1290–1297. 10.1002/jcp.24864
4
BruniO.KohlerM.NovelliL.KennedyD.LushingtonK.MartinJ.et al. (2012). The role of NREM sleep instability in child cognitive performance. Sleep35, 649–656. 10.5665/sleep.1824
5
CarotenutoM.EspositoM.CorteseS.LainoD.VerrottiA. (2016). Children with developmental dyslexia showed greater sleep disturbances than controls including problems initiating and maintaining sleep. Acta Paediatr.105, 1079–1082. 10.1111/apa.13472
6
CarotenutoM.EspositoM.PascottoA. (2010). Migraine and enuresis in children: an unusual correlation?Med. Hypotheses75, 120–122. 10.1016/j.mehy.2010.02.004
7
CarotenutoM.EspositoM.PrecenzanoF.CastaldoL.RoccellaM. (2011). Cosleeping in childhood migraine. Minerva Pediatr.63, 105–109.
8
ChemelliR. M.WillieJ. T.SintonC. M.ElmquistJ. K.ScammellT.LeeC.et al. (1999). Narcolepsy in orexin knockout mice: molecular genetics of sleep regulation. Cell98, 437–451. 10.1016/S0092-8674(00)81973-X
9
ChieffiS.ConsonM.CarlomagnoS. (2004). Movement velocity effects on kinaesthetic localization of spatial positions. Exp. Brain Res.158, 421–426. 10.1007/s00221-004-1916-z
10
ChieffiS.IachiniT.IavaroneA.MessinaG.ViggianoA.MondaM. (2014a). Flanker interference effects in a line bisection task. Exp. Brain Res.232, 1327–1334. 10.1007/s00221-014-3851-y
11
ChieffiS.IavaroneA.IaccarinoL.La MarraM.MessinaG.De LucaV.et al. (2014b). Age-related differences in distractor interference on line bisection. Exp. Brain Res.232, 3659–3664. 10.1007/s00221-014-4056-0
12
ChieffiS.IavaroneA.La MarraM.MessinaG.DaliaC.ViggianoA.et al. (2015). Vulnerability to distraction in schizophrenia. J Psychiatry18, 228. 10.4172/Psychiatry.1000228
13
ChieffiS.IavaroneA.ViggianoA.MondaM.CarlomagnoS. (2012). Effect of a visual distractor on line bisection. Exp. Brain Res.219, 489–498. 10.1007/s00221-012-3106-8
14
ChieffiS.MessinaG.VillanoI.MessinaA.EspositoM.MondaV.et al. (2017). Exercise influence on hippocampal function: possible involvement of orexin-A. Front. Physiol.8:85. 10.3389/fphys.2017.00085
15
ChieffiS.SecchiC.GentilucciM. (2009). Deictic word and gesture production: their interaction. Behav. Brain Res.203, 200–206. 10.1016/j.bbr.2009.05.003
16
ColonnaA.SmithA. B.PalD. K.GringrasP. (2015). Novel mechanisms, treatments, and outcome measures in childhood sleep. Front. Psychol.6:602. 10.3389/fpsyg.2015.00602
17
CoppolaG.ArcieriS.D'AnielloA.MessanaT.VerrottiA.SignorielloG.et al. (2010). Levetiracetam in submaximal subcutaneous pentylentetrazol-induced seizures in rats. Seizure19, 296–299. 10.1016/j.seizure.2010.03.004
18
CotmanC. W.BerchtoldN. C.ChristieL. A. (2007). Exercise builds brain health: key roles of growth factor cascades and inflammation. Trends Neurosci.30, 464–472. 10.1016/j.tins.2007.06.011
19
Di BernardoG.MessinaG.CapassoS.Del GaudioS.CipollaroM.PelusoG.et al. (2014). Sera of overweight people promote in vitro adipocyte differentiation of bone marrow stromal cells. Stem Cell Res. Ther.5:4. 10.1186/scrt393
20
EdwardsC. M. B.AbusnanaS.SunterD.MurphyK. G.GhateiM. A.BloomS. R. (1999). The effect of the orexins on food intake: comparison with neuropeptide Y, melanin-concentrating hormone and galanin. J. Endocrinol.160, R7–R12. 10.1677/joe.0.160R007
21
EspañaR. A.ScammellT. E. (2011). Sleep neurobiology from a clinical perspective. Sleep34, 845–858. 10.5665/SLEEP.1112
22
EspositoM.CarotenutoM. (2014). Intellectual disabilities and power spectra analysis during sleep: a new perspective on borderline intellectual functioning. J. Intellect. Disabil. Res.58, 421–429. 10.1111/jir.12036
23
EspositoM.PascottoA.GallaiB.ParisiL.RoccellaM.MarottaR.et al. (2012a). Can headache impair intellectual abilities in children? an observational study. Neuropsychiatr. Dis. Treat.8, 509–513. 10.2147/NDT.S36863
24
EspositoM.RoccellaM.ParisiL.GallaiB.CarotenutoM. (2013). Hypersomnia in children affected by migraine without aura: A questionnaire-based case-control study. Neuropsychiatr. Dis. Treat.9, 289–294. 10.2147/NDT.S42182
25
EspositoM.VerrottiA.GimiglianoF.RubertoM.AgostinelliS.ScuccimarraG.et al. (2012b). Motor coordination impairment and migraine in children: a new comorbidity?Eur. J. Pediatr.171, 1599–1604. 10.1007/s00431-012-1759-8
26
FlegalK. M.CarrollM. D.OgdenC. L.CurtinL. R. (2010). Prevalence and trends in obesity among US adults, 1999-2008. JAMA303, 235–241. 10.1001/jama.2009.2014
27
FrancoR.ZappavignaS.GigantinoV.LuceA.CantileM.CerroneM.et al. (2014). Urotensin II receptor determines prognosis of bladder cancer regulating cell motility/invasion. J. Exp. Clin. Cancer Res.33:48. 10.1186/1756-9966-33-48
28
HaraJ.BeuckmannC. T.NambuT.WillieJ. T.ChemelliR. M.SintonC. M.et al. (2001). Genetic ablation of orexin neurons in mice results in narcolepsy, hypophagia, and obesity. Neuron30, 345–354. 10.1016/S0896-6273(01)00293-8
29
HaraJ.YanagisawaM.SakuraiT. (2005). Difference in obesity phenotype between orexin-knockout mice and orexin neuron-deficient mice with same genetic background and environmental conditions. Neurosci. Lett.380, 239–242. 10.1016/j.neulet.2005.01.046
30
HarrisG. C.WimmerM.Aston-JonesG. (2005). A role for lateral hypothalamic orexin neurons in reward seeking. Nature437, 556–559. 10.1038/nature04071
31
HaynesA. C.ChapmanH.TaylorC.MooreG. B.CawthorneM. A.TadayyonM.et al. (2002). Anorectic, thermogenic and anti-obesity activity of a selective orexin-1 receptor antagonist in ob/ob mice. Regul. Pept.104, 153–159. 10.1016/S0167-0115(01)00358-5
32
HaynesA. C.JacksonB.ChapmanH.TadayyonM.JohnsA.PorterR. A.et al. (2000). A selective orexin-1 receptor antagonist reduces food consumption in male and female rats. Regul. Pept.96, 45–51. 10.1016/S0167-0115(00)00199-3
33
IavaroneA.PatrunoM.GaleoneF.ChieffiS.CarlomagnoS. (2007). Brief report: error pattern in an autistic savant calendar calculator. J. Autism Dev. Disord.37, 775–779. 10.1007/s10803-006-0190-2
34
JamesM. H.MahlerS. V.MoormanD. E.Aston-JonesG. (2016). Decade of orexin/hypocretin and addiction: where are we now?Curr. Top. Behav. Neurosci. [Epub ahead of print]. 10.1007/7854_2016_57
35
LevinB. E.Dunn-MeynellA. A.BalkanB.KeeseyR. E. (1997). Selective breeding for diet-induced obesity and resistance in Sprague-Dawley rats. Am. J. Physiol.273, R725–R730.
36
LevineJ. A. (2002). Non-exercise activity thermogenesis (NEAT). Best Pract. Res. Clin. Endocrinol. Metab.16, 679–702. 10.1053/beem.2002.0227
37
LevineJ. A.Lanningham-FosterL. M.McCradyS. K.KrizanA. C.OlsonL. R.KaneP. H.et al. (2005). Interindividual variation in posture allocation: possible role in human obesity. Science307, 584–586. 10.1126/science.1106561
38
LiY.GaoX. B.SakuraiT.van den PolA. N. (2002). Hypocretin/Orexin excites hypocretin neurons via a local glutamate neuron-A potential mechanism for orchestrating the hypothalamic arousal system. Neuron36, 1169–1181. 10.1016/S0896-6273(02)01132-7
39
LinL.FaracoJ.LiR.KadotaniH.RogersW.LinX.et al. (1999). The sleep disorder canine narcolepsy is caused by a mutation in the hypocretin (orexin) receptor 2 gene. Cell98, 365–376. 10.1016/S0092-8674(00)81965-0
40
LiuZ. W.GaoX. B. (2007). Adenosine inhibits activity of hypocretin/orexin neurons by the A1 receptor in the lateral hypothalamus: a possible sleep-promoting effect. J. Neurophysiol.97, 837–848. 10.1152/jn.00873.2006
41
LuX. Y.BagnolD.BurkeS.AkilH.WatsonS. J. (2000). Differential distribution and regulation of OX1 and OX2 orexin/hypocretin receptor messenger RNA in the brain upon fasting. Horm. Behav.37, 335–344. 10.1006/hbeh.2000.1584
42
MarraL.CantileM.ScognamiglioG.PerdonàS.La MantiaE.CerroneM. (2013). Deregulation of HOX B13 expression in urinary bladder cancer progression. Curr. Med. Chem.20, 833–839. 10.2174/0929867311320060008
43
Martin-FardonR.CauviG.KerrT. M.WeissF. (2016). Differential role of hypothalamic orexin/hypocretin neurons in reward seeking motivated by cocaine versus palatable food. Addict. Biol. [Epub ahead of print]. 10.1111/adb.12441
44
McCoyJ. G.StreckerR. E. (2011). The cognitive cost of sleep lost. Neurobiol. Learn. Mem.96, 564–582. 10.1016/j.nlm.2011.07.004
45
MensenA.PoryazovaR.HuegliG.BaumannC. R.SchwartzS.KhatamiR. (2015). The roles of dopamine and hypocretin in reward: a electroencephalographic study. PLoS ONE10:e0142432. 10.1371/journal.pone.0142432
46
MessinaA.De FuscoC.MondaV.EspositoM.MoscatelliF.ValenzanoA.et al. (2016). Role of the orexin system on the hypothalamus-pituitary-thyroid axis. Front. Neural Circuits10:66. 10.3389/fncir.2016.00066
47
MessinaG.DaliaC.TafuriD.MondaV.PalmieriF.DatoA.et al. (2014). Orexin-A controls sympathetic activity and eating behavior. Front. Psychol.5:997. 10.3389/fpsyg.2014.00997
48
MessinaG.De LucaV.ViggianoA.AscioneA.IannacconeT.ChieffiS.et al. (2013). Autonomic nervous system in the control of energy balance and body weight: personal contributions. Neurol. Res. Int.2013:639280. 10.1155/2013/639280
49
MessinaG.Di BernardoG.ViggianoA.De LucaV.MondaV.MessinaA.et al. (2016). Exercise increases the level of plasma orexin A in humans. J. Basic Clin. Physiol. Pharmacol.27, 611–616. 10.1515/jbcpp-2015-0133
50
MessinaG.MondaV.MoscatelliF.ValenzanoA. A.MondaG.EspositoT.et al. (2015). Role of Orexin system in obesity. Biol. Med.7:248. 10.4172/0974-8369.1000248
51
MignotE. (1998). Genetic and familial aspects of narcolepsy. Neurology50, S16–S22. 10.1212/WNL.50.2_Suppl_1.S16
52
MondaM.MessinaG.ScognamiglioI.LombardiA.MartinG. A.SperlonganoP.et al. (2014). Short-term diet and moderate exercise in young overweight men modulate cardiocyte and hepatocarcinoma survival by oxidative stress. Oxid. Med. Cell. Longev.2014:131024. 10.1155/2014/131024
53
MondaM.ViggianoA.ViggianoA.MondolaR.ViggianoE.MessinaG.et al. (2008). Olanzapine blocks the sympathetic and hyperthermic reactions due to cerebral injection of orexin A. Peptides29, 120–126. 10.1016/j.peptides.2007.10.016
54
MustA.SpadanoJ.CoakleyE. H.FieldA. E.ColditzG.DietzW. H. (1999). The disease burden associated with overweight and obesity aviva. JAMA282, 1523–1529. 10.1001/jama.282.16.1523
55
NambuT.SakuraiT.MizukamiK.HosoyaY.YanagisawaM.GotoK. (1999). Distribution of orexin neurons in the adult rat brain. Brain Res.827, 243–260. 10.1016/S0006-8993(99)01336-0
56
NaritaM.NagumoY.HashimotoS.NaritaM.KhotibJ.MiyatakeM.et al. (2006). Direct involvement of orexinergic systems in the activation of the mesolimbic dopamine pathway and related behaviors induced by morphine. J. Neurosci.26, 398–405. 10.1523/JNEUROSCI.2761-05.2006
57
Perez-LeightonC. E.BolandK.TeskeJ. A.BillingtonC.KotzC. M. (2012). Behavioral responses to orexin, orexin receptor gene expression, and spontaneous physical activity contribute to individual sensitivity to obesity. Am. J. Physiol. Endocrinol. Metab.303, E865–E874. 10.1152/ajpendo.00119.2012
58
PeyronC.FaracoJ.RogersW.RipleyB.OvereemS.CharnayY.et al. (2000). A mutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brains. Nat. Med.6, 991–997. 10.1038/79690
59
PeyronC.TigheD. K.van den PolA. N.de LeceaL.HellerH. C.SutcliffeJ. G.et al. (1998). Neurons containing hypocretin (orexin) project to multiple neuronal systems. J. Neurosci.18, 9996–10015.
60
PosarA.PizzaF.ParmeggianiA.PlazziG. (2014). Neuropsychological findings in childhood narcolepsy. J. Child Neurol.29, 1370–1376. 10.1177/0883073813508315
61
RaineroI.De MartinoP.PinessiL. (2008). Hypocretins and primary headaches: neurobiology and clinical implications. Expert Rev. Neurother.8, 409–416. 10.1586/14737175.8.3.409
62
SakuraiT.AmemiyaA.IshiiM.MatsuzakiI.ChemelliR. M.TanakaH.et al. (1998). Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior. Cell92, 573–585. 10.1016/S0092-8674(00)80949-6
63
SaperC. B.ChouT. C.ScammellT. E. (2001). The sleep switch: hypothalamic control of sleep and wakefulness. Trends Neurosci.24, 726–731. 10.1016/S0166-2236(00)02002-6
64
ShiuchiT.HaqueM. S.OkamotoS.InoueT.KageyamaH.LeeS.et al. (2009). Hypothalamic orexin stimulates feeding-associated glucose utilization in skeletal muscle via sympathetic nervous system. Cell Metab.10, 466–480. 10.1016/j.cmet.2009.09.013
65
ThannickalT. C.MooreR. Y.NienhuisR.RamanathanL.GulyaniS.AldrichM.et al. (2000). Reduced number of hypocretin neurons in human narcolepsy. Neuron27, 469–474. 10.1016/S0896-6273(00)00058-1
66
TrivediP.YuH.MacNeilD. J.Van der PloegL. H.GuanX. M. (1998). Distribution of orexin receptor mRNA in the rat brain. FEBS Lett.438, 71–75. 10.1016/S0014-5793(98)01266-6
67
TsujinoN.YamanakaA.IchikiK.MurakiY.KilduffT. S.YagamiK. I. (2005). Cholecystokinin activates orexin/hypocretin neurons through the cholecystokinin A receptor. J. Neurosci.25, 7459–7469. 10.1523/JNEUROSCI.1193-05.2005
68
TsunematsuT.FuL. Y.YamanakaA.IchikiK.TanoueA.SakuraiT.et al. (2008). Vasopressin increases locomotion through a V1a receptor in orexin/hypocretin neurons: implications for water homeostasis. J. Neurosci.28, 228–238. 10.1523/JNEUROSCI.3490-07.2008
69
VerrottiA.CarotenutoM.AltieriL.ParisiP.TozziE.BelcastroV.et al. (2015). Migraine and obesity: metabolic parameters and response to a weight loss programme. Pediatr. Obes.10, 220–225. 10.1111/ijpo.245
70
VerrottiA.Di FonzoA.AgostinelliS.CoppolaG.MargiottaM.ParisiP. (2012). Obese children suffer more often from migraine. Acta Paediatr. Int. J. Paediatr.101, e416–e421. 10.1111/j.1651-2227.2012.02768.x
71
ViggianoA.ChieffiS.TafuriD.MessinaG.MondaM.De LucaB. (2014). Laterality of a second player position affects lateral deviation of basketball shooting. J. Sports Sci.32, 46–52. 10.1080/02640414.2013.805236
72
ViggianoA.NicodemoU.ViggianoE.MessinaG.ViggianoA.MondaM.et al. (2010). Mastication overload causes an increase in O 2 - production into the subnucleus oralis of the spinal trigeminal nucleus. Neuroscience166, 416–421. 10.1016/j.neuroscience.2009.12.071
73
ViggianoA.VicidominiC.MondaM.CarleoD.CarleoR.MessinaG.et al. (2009). Fast and low-cost analysis of heart rate variability reveals vegetative alterations in noncomplicated diabetic patients. J. Diabetes Complicat.23, 119–123. 10.1016/j.jdiacomp.2007.11.009
74
VillanoI.MessinaA.ValenzanoA.MoscatelliF.EspositoT.MondaV.et al. (2017). Basal forebrain cholinergic system and orexin neurons: effects on attention. Front. Behav. Neurosci.11:10. 10.3389/fnbeh.2017.00010
75
WalkerL. C.LawrenceA. J. (2016). The role of orexins/hypocretins in alcohol use and abuse. Curr. Top Behav. Neurosci. [Epub ahead of print]. 10.1007/7854_2016_55
76
WaynerM. J.ArmstrongD. L.PhelixC. F.OomuraY. (2004). Orexin-A (Hypocretin-1) and leptin enhance LTP in the dentate gyrus of rats in vivo. Peptides25, 991–996. 10.1016/j.peptides.2004.03.018
77
WilliamsR. H.JensenL. T.VerkhratskyA.FuggerL.BurdakovD. (2007). Control of hypothalamic orexin neurons by acid and CO2. Proc. Natl. Acad. Sci. U.S.A.104, 10685–10690. 10.1073/pnas.0702676104
78
XieX.CrowderT. L.YamanakaA.MorairtyS. R.LeWinterR. D.SakuraiT. (2006). GABA(B) receptor-mediated modulation of hypocretin/orexin neurones in mouse hypothalamus. J. Physiol.574, 399–414. 10.1113/jphysiol.2006.108266
79
XuT. R.YangY.WardR.GaoL.LiuY. (2013). Orexin receptors: multi-functional therapeutic targets for sleeping disorders, eating disorders, drug addiction, cancers and other physiological disorders. Cell. Signal.25, 2413–2423. 10.1016/j.cellsig.2013.07.025
80
YamanakaA.BeuckmannC. T.WillieJ. T.HaraJ.TsujinoN.MiedaM.et al. (2003a). Hypothalamic orexin neurons regulate arousal according to energy balance in mice. Neuron38, 701–713. 10.1016/S0896-6273(03)00331-3
81
YamanakaA.MurakiY.IchikiK.TsujinoN.KilduffT. S.GotoK.et al. (2006). Orexin neurons are directly and indirectly regulated by catecholamines in a complex manner. J. Neurophysiol.96, 284–298. 10.1152/jn.01361.2005
82
YamanakaA.MurakiY.TsujinoN.GotoK.SakuraiT. (2003b). Regulation of orexin neurons by the monoaminergic and cholinergic systems. Biochem. Biophys. Res. Commun.303, 120–129. 10.1016/S0006-291X(03)00299-7
83
YangL.ZouB.XiongX.PascualC.XieJ.MalikA.et al. (2013). Hypocretin/orexin neurons contribute to hippocampus-dependent social memory and synaptic plasticity in mice. J. Neurosci.33, 5275–5284. 10.1523/JNEUROSCI.3200-12.2013
84
YokoboriE.KojimaK.AzumaM.KangK. S.MaejimaS.UchiyamaM.et al. (2011). Stimulatory effect of intracerebroventricular administration of orexin A on food intake in the zebrafish, Danio rerio. Peptides32, 1357–1362. 10.1016/j.peptides.2011.05.010
85
ZhaoX.Xue ZhangR.TangS.Yan RenY.Xia YangW.LiuX.et al. (2014). Orexin-A-induced ERK 1/2 activation reverses impaired spatial learning and memory in pentylenetetrazol-kindled rats via OX1R-mediated hippocampal neurogenesis. Peptides54, 140–147. 10.1016/j.peptides.2013.11.019
86
ZinkA. N.Perez-LeightonC. E.KotzC. M. (2014). The orexin neuropeptide system: physical activity and hypothalamic function throughout the aging process. Front. Syst. Neurosci.8:211. 10.3389/fnsys.2014.00211
Summary
Keywords
orexin, obesity, emotional stress, narcolepsy
Citation
Chieffi S, Carotenuto M, Monda V, Valenzano A, Villano I, Precenzano F, Tafuri D, Salerno M, Filippi N, Nuccio F, Ruberto M, De Luca V, Cipolloni L, Cibelli G, Mollica MP, Iacono D, Nigro E, Monda M, Messina G and Messina A (2017) Orexin System: The Key for a Healthy Life. Front. Physiol. 8:357. doi: 10.3389/fphys.2017.00357
Received
25 January 2017
Accepted
15 May 2017
Published
31 May 2017
Volume
8 - 2017
Edited by
Giovanni Li Volti, University of Catania, Italy
Reviewed by
Ivana Sirangelo, Università degli Studi della Campania “Luigi Vanvitelli” Caserta, Italy; Mauro Pessia, University of Perugia, Italy
Updates
Copyright
© 2017 Chieffi, Carotenuto, Monda, Valenzano, Villano, Precenzano, Tafuri, Salerno, Filippi, Nuccio, Ruberto, De Luca, Cipolloni, Cibelli, Mollica, Iacono, Nigro, Monda, Messina and Messina.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Vincenzo Monda mondavincenzo@gmail.com
This article was submitted to Integrative Physiology, a section of the journal Frontiers in Physiology
†These authors have contributed equally to this work.
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.